The next board meeting for Apellis Pharmaceuticals Inc is on 01 Aug 2025 for the purpose of Apellis Pharmaceuticals Inc Second Quarter Earnings Results for 2025See details
Apellis Pharmaceuticals Inc has a share price target of US$ 36, revenue growth forecast of 9.8%, and profit growth estimate of -7.1% for FY25, based on top 22 analyst calls.